Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    5.00 (1.10%)
Bid:
455.50
Ask:
460.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director/PDMR Shareholding

11 Sep 2020 16:12

RNS Number : 8017Y
Frontier Developments PLC
11 September 2020
Β 

Frontier Developments plc

ExerciseΒ of Options, Director/PDMR Shareholding and Total Voting Rights

Frontier Developments plc (AIM: FDEV, "Frontier", the "Company") announces that employees of the Company have exercised in aggregate options over 401,339 ordinary shares of 0.5 pence each in the Company ("Ordinary Shares") under the Company's share option plans. Of the Ordinary Shares exercised by employees, three Directors of the Company have exercised 279,889 share options (the "Options") and subsequently sold 347,351 Ordinary Shares.

The Options exercised and Ordinary Shares sold by the Directors are set out in the tables below, together with the total number of Ordinary Shares each Director is interested in and holds under option.

Β 

Name of Director

Role

Number of Options exercised

Weighted average exercise price of Options exercised

Total Number of Options held following the exercise

David Gammon(1)

Non-Executive Chairman

12,500

230p

Nil

Alex Bevis

CFO & Company Secretary

200,000

250p

167,593

Jonathan Watts

Chief Creative Officer

67,389

199p

159,308

Β 

Resultant Holding

Name of Director

Ordinary shares sold

Price of Ordinary shares sold

Number of Ordinary Shares held following the sale

Percentage of issued share capital

David Gammon(1)

59,962

2,386p

290,000

0.74%

Alex Bevis

200,000

2,386p

17,000

0.04%

Jonathan Watts

87,389

2,386p

20,000

0.05%

Β 

(1)David Gammon, together with his family, holds and held beneficial interest in these Options and Ordinary Shares through Rockspring, a UK company, where David is a Director.

Β 

Total Voting Rights

In accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that, following the exercise of Options, its issued share capital consists of 39,191,699 Ordinary Shares.

The Company does not currently hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 39,191,699.

Β 

The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Β 

Β 

Enquiries:

Β 

Frontier DevelopmentsΒ Β +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFOΒ 

Β 

Liberum - Nomad and Joint Broker +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

Β 

Jefferies - Joint BrokerΒ Β +44 (0)20 7029 8000

Max Jones / William Brown

Β 

Tulchan CommunicationsΒ Β +44 (0)20 7353 4200

Matt Low / Deborah Roney / David Allchurch

Β 

Β 

About Frontier Developments plc

Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

Β 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1. Β 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Gammon

2. Β 

Reason for the notification

a)

Position/status: Non-Executive Chairman

b)

Initial notification/Amendment: Initial Notification

3. Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4. Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transaction:

a) Exercise of Options

b) Disposal of Ordinary Shares

c)

Β 

Β 

Price(s) and volume(s):

a)

Exercise Price(s)

Volume(s)

230p

12,500

Β 

b)

Sale Price(s)

Volume(s)

2,386p

12,500

2,386p

47,462

d)

Aggregated information:

a) n/a - Single transaction

b)

Average Sale Price

Volume

2,386p

59,962

e)

Date of the transaction(s): 11 September 2020

f)

Place of the transaction:

a) Outside a trading venue

b) London Stock Exchange

Β 

1. Β 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Alex Bevis

2. Β 

Reason for the notification

a)

Position/status: CFO & Company Secretary

b)

Initial notification/Amendment: Initial Notification

3. Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4. Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transaction:

a) Exercise of Options

b) Disposal of Ordinary Shares

c)

Β 

Β 

Price(s) and volume(s):

a)

Exercise Price(s)

Volume(s)

250p

200,000

b)

Sale Price(s)

Volume(s)

2,386p

200,000

d)

Aggregated information:

a) n/a - Single transaction

b) n/a - Single transaction

e)

Date of the transaction(s): 11 September 2020

f)

Place of the transaction:

a) Outside a trading venue

b) London Stock Exchange

Β 

1. Β 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jonathan Watts

2. Β 

Reason for the notification

a)

Position/status: Chief Creative Officer

b)

Initial notification/Amendment: Initial Notification

3. Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4. Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transaction:

a) Exercise of Options

b) Disposal of Ordinary Shares

c)

Β 

Β 

Price(s) and volume(s):

a)

Exercise Price(s)

Volume(s)

406p

7,389

174p

60,000

b)

Sale Price(s)

Volume(s)

2,386p

67,389

2,385p

20,000

d)

Aggregated information:

a)

Average Exercise Price

Volume

199p

67,389

b)

Average Sale Price

Volume

2,386p

87,389

e)

Date of the transaction(s): 11 September 2020

f)

Place of the transaction:

a) Outside a trading venue

b) London Stock Exchange

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKKDBDPBKDDCD
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.